Please wait while we prepare everything...
Please wait while we prepare everything...
Please wait while we prepare everything...

Human Metapneumovirus (HMPV), a member of the Pneumoviridae family, is a respiratory virus that affects individuals across all age groups, particularly young children, the elderly, and immunocompromised individuals. This is not a new virus; it has been reported since 2001. Common symptoms include coughing, nasal congestion, fever, and, in severe cases, wheezing or difficulty breathing. The virus can lead to complications such as pneumonia or bronchiolitis in vulnerable populations. Remember, Prevention is the key! Prevention through good hygiene and awareness remains the most effective way to combat the virus.
Certain groups are more susceptible to severe HMPV infections:
HMPV is highly contagious and spreads through respiratory droplets from sneezes or coughs, close contact, or touching contaminated surfaces followed by contact with the mouth, nose, or eyes. The virus is most active in late winter and spring.
While symptoms can vary between individuals, the most common signs include:
In children, the virus often presents as severe respiratory infections, requiring close monitoring.
Preventive measures can significantly reduce the risk of HMPV infections:
Healthcare providers usually diagnose HMPV based on symptoms and health history. Laboratory tests, such as PCR or antigen tests, are performed in severe cases or during outbreaks to confirm the diagnosis.
Currently, no specific antiviral medication or vaccine exists for HMPV. Treatment focuses on managing symptoms:
Seek medical care if symptoms worsen, include difficulty breathing, or occur alongside chronic health conditions like asthma or COPD.
Amrita Hospital offers dedicated respiratory and infectious medicine departments to address a wide range of breathing-related conditions and infections caused by bacteria, parasites, viruses, and fungi.
It is better advised to consult our expert doctors from respiratory medicine or infectious departments for expert guidance and support.
HMPV is not as deadly as COVID-19, but it is a significant respiratory virus that requires attention, particularly for vulnerable populations like young children, the elderly, and those with weakened immune systems. Unlike COVID-19, HMPV is not a global pandemic-level threat, but its symptoms can lead to severe complications, such as pneumonia or bronchiolitis, in vulnerable individuals. It is essential to understand this virus and take preventive measures to protect against it. HMPV primarily causes upper respiratory symptoms similar to the common cold, while COVID-19 often leads to systemic symptoms and higher rates of severe complications.
Yes, HMPV shares similarities with RSV and the flu, particularly in symptoms. However, unlike RSV, it also significantly affects older adults, and there is currently no vaccine available for HMPV.
Yes, reinfections are possible as immunity is not long-lasting.
Mild cases resolve within a week or two, but severe infections can lead to prolonged recovery.
Highly contagious, HMPV spreads through respiratory droplets and contact with contaminated surfaces.
Pregnant women with HMPV may face respiratory complications, affecting maternal and foetal health. Preventive measures are crucial.